Correlation Between Cardiol Therapeutics and Deciphera Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cardiol Therapeutics and Deciphera Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiol Therapeutics and Deciphera Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardiol Therapeutics Class and Deciphera Pharmaceuticals LLC, you can compare the effects of market volatilities on Cardiol Therapeutics and Deciphera Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiol Therapeutics with a short position of Deciphera Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiol Therapeutics and Deciphera Pharmaceuticals.
Diversification Opportunities for Cardiol Therapeutics and Deciphera Pharmaceuticals
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Cardiol and Deciphera is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Cardiol Therapeutics Class and Deciphera Pharmaceuticals LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Deciphera Pharmaceuticals and Cardiol Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiol Therapeutics Class are associated (or correlated) with Deciphera Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Deciphera Pharmaceuticals has no effect on the direction of Cardiol Therapeutics i.e., Cardiol Therapeutics and Deciphera Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cardiol Therapeutics and Deciphera Pharmaceuticals
Given the investment horizon of 90 days Cardiol Therapeutics Class is expected to generate 1.76 times more return on investment than Deciphera Pharmaceuticals. However, Cardiol Therapeutics is 1.76 times more volatile than Deciphera Pharmaceuticals LLC. It trades about 0.06 of its potential returns per unit of risk. Deciphera Pharmaceuticals LLC is currently generating about -0.02 per unit of risk. If you would invest 70.00 in Cardiol Therapeutics Class on September 4, 2024 and sell it today you would earn a total of 87.00 from holding Cardiol Therapeutics Class or generate 124.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 30.71% |
| Values | Daily Returns |
Cardiol Therapeutics Class vs. Deciphera Pharmaceuticals LLC
Performance |
| Timeline |
| Cardiol Therapeutics |
| Deciphera Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cardiol Therapeutics and Deciphera Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardiol Therapeutics and Deciphera Pharmaceuticals
The main advantage of trading using opposite Cardiol Therapeutics and Deciphera Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiol Therapeutics position performs unexpectedly, Deciphera Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deciphera Pharmaceuticals will offset losses from the drop in Deciphera Pharmaceuticals' long position.| Cardiol Therapeutics vs. Flora Growth Corp | Cardiol Therapeutics vs. ABVC Biopharma | Cardiol Therapeutics vs. Indaptus Therapeutics | Cardiol Therapeutics vs. HCW Biologics |
| Deciphera Pharmaceuticals vs. ANI Pharmaceuticals | Deciphera Pharmaceuticals vs. Phibro Animal Health | Deciphera Pharmaceuticals vs. Prestige Brand Holdings | Deciphera Pharmaceuticals vs. Evotec SE ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |